NewsRx

Search our medical news database

Aeolus Pharmaceuticals, Inc.

Aeolus Pharmaceuticals Completes Second Closing of Senior Convertible Debt Financing

Published in Drug Law Weekly, September 16th, 2008

Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced that it has raised an additional $125,000 through the sale of $125,000 in aggregate principal amount of its newly issued Senior Convertible Notes and warrants to selected institutional investors. The investors have also agreed, upon the satisfaction of certain conditions by the Company, to invest another $375,000 over the next three months and have the option to invest an additional $4,000,000 at any time on or before February 1, 2010. The Company previously raised $500,000 through the sale of Senior Convertible Notes and warrants from the same institutional investors in August 2008.

The Notes bear interest at a rate...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook